Biocept CEO Michael Nall's 2019 pay jumps 177% to $1.2M
Biocept reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Biocept reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three Biocept executives received on average a compensation package of $829K, a 129% increase compared to previous year.
Average pay of disclosed executives at Biocept
Michael W. Nall, Chief Executive Officer, received $1.2M in total, which increased by 177% compared to 2018. 51% of Nall's compensation, or $617K, was in option awards. Nall also received $154K in non-equity incentive plan, $435K in salary, as well as $9.6K in other compensation.
Timothy C. Kennedy, Chief Financial Officer, received a compensation package of $827K, which increased by 130% compared to previous year. 44% of the compensation package, or $366K, was in option awards.
Edwin Hendrick, SVP Sales, Chief Commercial Officer, earned $446K in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.